The invention relates to novel ring-fused 4-aminopyrimidines, to methods for the production thereof, to the use thereof on its own or combined for the treatment and/or prophylaxis of diseases and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.